SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HuMAB companies
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who started this subject7/4/2000 3:57:01 PM
From: Chi Wong  Read Replies (1) of 1022
 
Humanized vs Fully human? (2 questions)

I'm a little confused here.

1)Is there a significant difference if both are not rejected by the body?

I'm a long time investor in IMGN which has a technology called "Tumour Activated Prodrug" which uses the antibody's specificity to target cancerous cells. If the payload (somekind of toxin like dc1 or dm1) can be delivered inside the cell the company says the cell dies 100% of the time.

2)Without a company like IMGN to attach a cytotoxic agent what good are all these other HuMabs?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News